$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
【阿帕鲁胺Apalutamide价格大评比】阿帕鲁什么价?
2025-10-19 11:44:20
Check Details
阿帕鲁胺中国上市多少钱一盒?阿帕鲁胺网络上能买到正品吗?
2025-10-19 11:44:20
Check Details
【最新关注】阿帕鲁胺Apalutamide说明书|阿帕鲁胺中国上市价格
2025-10-19 11:44:20
Check Details
今日重磅消息来袭,前列腺癌新药达罗他胺能显著延长生存期
2025-10-19 11:44:20
Check Details
进口前列癌药达罗他胺价钱多少?达罗他胺2021最新说明书
2025-10-19 11:44:20
Check Details
前列腺癌患者的新选择,达罗他胺能有效控制病情,延长患者生存时间
2025-10-19 11:44:20
Check Details
【新药速递】达洛鲁胺薄膜片,治疗前列腺癌有哪些优势?
2025-10-19 11:44:20
Check Details
达洛鲁胺我国是否批准上市了?达洛鲁胺进2021医保了吗?
2025-10-19 11:44:20
Check Details
靶向药达洛鲁胺能显著改善非转移性前列腺癌患者的生存率
2025-10-19 11:44:20
Check Details
【前列腺癌新药】达洛鲁胺在国内获批,更安全,更高效
2025-10-19 11:44:20
Check Details
安森珂(阿帕鲁胺)是什么药?2分钟带你看完安森珂药品说明书
2025-10-19 11:44:20
Check Details
前列腺癌新药安森珂(阿帕他胺)效果如何?哪些人适合用安森珂?
2025-10-19 11:44:20
Check Details
1
2
...
1548
1549
1550
1551
1552
1553
1554
...
4158
4159
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Pemigatinib vs. Anlotinib: Key Differences Between FGFR-Targeted Therapy and Multi-Target Anti-Angiogenic Treatment
2
Lapatinib: A Targeted Anticancer Agent — Not Merely Symptom Relief
3
Lapatinib: Proper Administration Guide and Key Precautions
4
Capivasertib (Truqap) Complete Medication Guide: Indications, Dosing, Safety, and Precautions
5
Cemiplimab Storage and Handling Guide
6
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Dosing Duration, Efficacy Comparison, and Long-Term Management
7
Belzutifan (Welireg): Comprehensive Guide to the First HIF-2α Inhibitor — Indications, Dosing, and Safety Monitoring
8
Encorafenib (Braftovi): Comprehensive Guide to BRAF V600 Inhibitor Indications, Dose Regimens by Tumor Type, and Administration Requirements
9
Alpelisib vs Inavolisib: How to Choose Between Two PI3Kα Inhibitors in PIK3CA-Mutated Breast Cancer
10
Selumetinib: The First MEK1/2 Inhibitor Approved for Inoperable Plexiform Neurofibromas in NF1
11
FIGHT-302 Phase 3 Trial: First-Line Pemigatinib Significantly Improves PFS Over Chemotherapy in FGFR2-Rearranged Cholangiocarcinoma
12
Selpercatinib Dosing Guide: Weight-Based Precision Targeting for RET-Driven Tumors